0 CHECKOUT

PRODUCT FILTERS

REGION

20
6
5
3
3

COUNTRY

2
2
1
1
1

CATEGORIES

  • 38
  • 18
  • 6
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

6
9
11
62

PUBLISHED

0
6
7
62

PRODUCT TYPE

57
3
2

Search for: "Rheumatoid Arthritis Therapeutics Market in Australia"

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs

This report provides in-depth analysis of Rheumatoid Arthritis (RA) market within the Asia-Pacific (APAC) market covering the four countries of Australia, China, India and Japan. The report provides...

Published:  May 2015
Price:  From

Asia Pacific Autoimmune Disorders Treatment Market - Opportunities and Forecasts, 2014 - 2022

Graves' disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence...

Published:  August 2016
Price:  From

Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth

GBI Research, the leading business intelligence provider, has released its latest research, “Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch...

Published:  December 2012
Price:  From

Autoimmune Disease Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple Sclerosis, Psoriasis, Crohns...

Published:  October 2011
Price:  From

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new PharmaPoint report, “PharmaPoint: Rheumatoid Arthritis - Global...

Published:  February 2013
Price:  From

Rheumatoid Arthritis Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Rheumatoid Arthritis Therapeutics in US$ Million The report provides separate comprehensive analytics for US, Japan, Europe, Latin America and Rest of...

Published:  February 2010
Price:  From

Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline

“Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline“ provides insights and analysis into the...

Published:  July 2013
Price:  From

Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis

Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From

Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis

Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fostamatinib (Rheumatoid Arthritis) Forecast and Market...

Published:  November 2012
Price:  From

Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis

Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From

Sarilumab (Rheumatoid Arthritis) Forecast and Market Analysis

Sarilumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Sarilumab (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From

Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016

Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016 Summary ‘Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016’, provides...

Published:  June 2016
Price:  From

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new Country report, “PharmaPoint: Rheumatoid Arthritis - Australia...

Published:  November 2012
Price:  From

Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis

Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast...

Published:  November 2012
Price:  From

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From

Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the...

Published:  December 2014
Price:  From

Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It...

Published:  December 2014
Price:  From

Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It...

Published:  December 2014
Price:  From
Loading Indicator

Our Clients

  • Abbott Laboratories Ltd.
  • Ford Motor Company
  • Honeywell International, Inc.
  • Nike, Inc.
  • Deloitte LLP.
  • IMAX Corporation